Blockade of HMGB1 with antagonists has been verified as an effective treatment strategy for animal stroke models, including GA [50], HMGB1 A box, and anti-HMGB1 monoclonal antibody [51]. The gene discussed is HMGB1; the disease is stroke disorder.